Sales up at Janssen in Japan despite mainstay challenges
This article was originally published in Scrip
Executive Summary
Total sales at Janssen Pharmaceutical in Japan rose by 3% to ¥80.5 billion ($868.4 million) in calendar 2009, despite challenging conditions for several mainstay products.